TELA Bio Inc logo

TELA - TELA Bio Inc Share Price

$14.15 -0.7  -4.4%

Last Trade - 9:00pm

Sector
Healthcare
Size
Small Cap
Market Cap £156.1m
Enterprise Value £119.0m
Revenue £12.7m
Position in Universe 4204th / 6623
Bullish
Bearish
Unlock TELA Revenue
Momentum
Relative Strength (%)
1m -11.8%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -37.1%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2014 2015 2016 2017 2018 2019 2020E 2021E CAGR / Avg
0.000 0.000 0.000 4.25 8.27 15.4 18.4 35.8 +90.8%
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the nine months ended 30 September 2020, TELABio Inc revenues increased 19% to $12.5M. Net lossapplicable to common stockholders decreased 8% to $21M.Revenues reflect an increase in demand for the Company'sproducts and services due to favorable market conditions.Lower net loss reflects Research and development -Balancing va decrease of 11% to $2.8M (expense), Interestexpense decrease of 2% to $2.7M (expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Latest News & Insights for TELA
Graphical History

Revenue

TELA Revenue Unlock TELA Revenue

Net Income

TELA Net Income Unlock TELA Revenue

Normalised EPS

TELA Normalised EPS Unlock TELA Revenue

PE Ratio Range

TELA PE Ratio Range Unlock TELA Revenue

Dividend Yield Range

TELA Dividend Yield Range Unlock TELA Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
TELA EPS Forecasts Unlock TELA Revenue
Profile Summary

TELA Bio Inc. is a medical technology company. The Company is focused on designing, developing and marketing tissue reinforcement materials for soft tissue reconstruction. It offers a portfolio of products and solutions for care in hernia repair, abdominal wall reconstruction and plastic and reconstructive surgery. Its portfolio of products, the OviTex Reinforced Tissue Matrix (OviTex), can be used for ventral hernia repair and abdominal wall reconstruction, inguinal hernia repair and hiatal hernia repair. Its OviTex PRS Reinforced Tissue Matrix (OviTex PRS) addresses needs in plastic and reconstructive surgery. OviTex PRS product is designed for use in implantation to reinforce soft tissue where weakness exists in patients requiring soft tissue repair or reinforcement in plastic and reconstructive surgery.

Directors
Last Annual December 31st, 2019
Last Interim September 30th, 2020
Incorporated April 17, 2012
Public Since November 8, 2019
No. of Shareholders: 95
No. of Employees: 89
Sector Healthcare
Industry Healthcare Equipment & Supplies
Index Nasdaq Composite ,
Exchange NASDAQ Global Market
Shares in Issue 14,432,285
Free Float (0.0%)
Eligible for
ISAs
SIPPs
TELA Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for TELA
Upcoming Events for TELA
Frequently Asked Questions for TELA Bio Inc
What is the TELA Bio Inc share price?

As of 9:00pm, shares in TELA Bio Inc are trading at $14.15, giving the company a market capitalisation of £156.1m. This share price information is delayed by 15 minutes.

How has the TELA Bio Inc share price performed this year?

Shares in TELA Bio Inc are currently trading at $14.15 and the price has moved by -5.85% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the TELA Bio Inc price has moved by -19.48% over the past year.

What are the analyst and broker recommendations for TELA Bio Inc?

There are no analysts currently covering TELA Bio Inc.

When will TELA Bio Inc next release its financial results?

TELA Bio Inc is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-09-30
What is the TELA Bio Inc dividend yield?

TELA Bio Inc does not currently pay a dividend.

Does TELA Bio Inc pay a dividend?

TELA Bio Inc does not currently pay a dividend.

When does TELA Bio Inc next pay dividends?

TELA Bio Inc does not currently pay a dividend.

How do I buy TELA Bio Inc shares?

To buy shares in TELA Bio Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of TELA Bio Inc?

Shares in TELA Bio Inc are currently trading at $14.15, giving the company a market capitalisation of £156.1m.

Where are TELA Bio Inc shares listed? Where are TELA Bio Inc shares listed?

Here are the trading details for TELA Bio Inc:

Country of listing: United States
Exchange: NMQ
Ticker Symbol: TELA
What kind of share is TELA Bio Inc?

Based on an overall assessment of its quality, value and momentum, TELA Bio Inc is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a TELA Bio Inc share price forecast 2021?

Shares in TELA Bio Inc are currently priced at $14.15. At that level they are trading at 35.14% discount to the analyst consensus target price of 0.00.

Analysts covering TELA Bio Inc currently have a consensus Earnings Per Share (EPS) forecast of -2.175 for the next financial year.

How can I tell whether the TELA Bio Inc share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like TELA Bio Inc. Over the past six months, the relative strength of its shares against the market has been -11.44%. At the current price of $14.15, shares in TELA Bio Inc are trading at 0.96% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the TELA Bio Inc PE Ratio?

We were not able to find PE ratio data for TELA Bio Inc.

Who are the key directors of TELA Bio Inc?

TELA Bio Inc's management team is headed by:

Antony Koblish - PRE
Maarten Persenaire - CFD
Ellis Greenhalgh - CTO
Federica OBrien - IND
Nora Brennan - CFO
kurt Azarbarzin - IND
Vince Burgess - IND
Adele Oliva - IND
Peter Murphy - OTH
Douglas Evans - CHM
Lisa Colleran - IND
Who are the major shareholders of TELA Bio Inc?

Here are the top five shareholders of TELA Bio Inc based on the size of their shareholding:

OrbiMed Advisors, LLC Investment Advisor/Hedge Fund
Percentage owned: 20.98% (3.03m shares)
Quaker Partners Management, L.P. Venture Capital
Percentage owned: 12.13% (1.75m shares)
Essex Woodlands Management, Inc. Venture Capital
Percentage owned: 10.22% (1.48m shares)
RTW Investments L.P. Investment Advisor/Hedge Fund
Percentage owned: 9.55% (1.38m shares)
Pacira Pharmaceuticals, Inc. Corporation
Percentage owned: 5.36% (774k shares)
Similar to TELA
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.